Abstract CT125: A phase 1/2 randomized study of IGM-2323 in relapsed/refractory non-Hodgkin lymphomas

Authors: Loretta Nastoupil, Elizabeth Budde, Won Seog Kim, Ajay Gopal, Chan Cheah, Ian Flinn, Gareth Gregory, Matthew Matasar, Catherine Diefenbach, Matthew Ku, Sung-Soo Yoon, Ibrahim Qazi, Rachel Wei, Maya Leabman, Genevive Hernandez, Iris Sison, Bruce Keyt, Thomas Manley, Phillipe Armand

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-ct125

Source: Full article